Leticia De Mattos‐Arruda

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

Leticia De Mattos‐Arruda, Regina Mayor, Charlotte K.Y. Ng et al. · Nature Communications · 2015 · 822 citations · Full text

Plasma Ctdna, Pathology, High-grade Gliomas +19

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

François‐Clément Bidard, Dieter Peeters, Tanja Fehm et al. · The Lancet Oncology · 2014 · 815 citations

Metastatic Breast Cancer, Breast Oncology, Clinical Validity +8

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

Javier Pascual, Gerhardt Attard, François‐Clément Bidard et al. · Annals of Oncology · 2022 · 586 citations · Full text

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

Leticia De Mattos‐Arruda, Britta Weigelt, Javier Cortés et al. · Annals of Oncology · 2014 · 368 citations · Full text

Genetic Testing, Engineering, Somatic Variant +12

Prognostic Impact of Pregnancy After Breast Cancer According to Estrogen Receptor Status: A Multicenter Retrospective Study

Hatem A. Azim, Niels Kroman, Marianne Paesmans et al. · Journal of Clinical Oncology · 2012 · 245 citations · Full text